Vanda Pharmaceuticals’ Imsidolimab BLA Accepted by FDA for Generalized Pustular Psoriasis Treatment
Vanda Pharmaceuticals has received FDA acceptance for its Biologics License Application (BLA) seeking approval of imsidolimab as a treatment for…
Vanda Pharmaceuticals has received FDA acceptance for its Biologics License Application (BLA) seeking approval of imsidolimab as a treatment for…
Texas Instruments’ shares declined recently as investors adjusted expectations around the pace of recovery in its end markets. Despite positive…
The global deep learning market, valued at approximately $64.92 billion in 2026, is on track to surpass $296 billion by…
Delta Resources Limited has strengthened its leadership team with the appointment of Ron Kopas as Chief Executive Officer, bringing extensive…
“The recent announcement regarding the adjournment of the ETP securityholders’ meeting highlights ongoing challenges for leveraged and inverse exchange-traded products…
“As markets navigate a rotation from growth to value amid steady global growth forecasts of around 2.8%, undervalued opportunities emerge…
“In a strategic move that bolsters its advisory expertise, Star Mountain Capital has welcomed Paul Efron, a longtime Goldman Sachs…
In a recent insider transaction, Protagonist Therapeutics director William D. Waddill exercised stock options and sold 20,000 shares of PTGX…
The global confectionery market, valued at USD 227.58 billion in 2026, is on track to surpass USD 299.18 billion by…
Maison Battat has launched the 2026 Keepsake Collection for Our Generation, a full-year series of limited-edition seasonal 18-inch dolls exclusively…